These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 13454501)

  • 1. [First results concerning the effects of the cytostatic drug Bayer E-39].
    VERGA P; PERRONE V
    Riforma Med; 1957 Jun; 71(22):604-7. PubMed ID: 13454501
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical results with Bayer E 39].
    HINTERBERGER K; KRETZ J
    Krebsarzt; 1957 Jun; 12(3):157-66. PubMed ID: 13450293
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of plasmocytoma with a ethyleneiminoquinone derivative (Bayer E 39 cytostatic)].
    DOENECKE F; HERMANN G
    Medizinische; 1957 May; (18):686-9. PubMed ID: 13440425
    [No Abstract]   [Full Text] [Related]  

  • 4. [Paradoxical effects of E 39].
    DUCHESNAY G
    Bull Med; 1957 Jan; 71(1):22. PubMed ID: 13413431
    [No Abstract]   [Full Text] [Related]  

  • 5. [Preliminary study on the use of the cytostatic drug E 39 in the therapy of prostate carcinoma].
    CHIEREGO F; FABRIS P
    Riforma Med; 1957 Jun; 71(22):615-8. PubMed ID: 13454503
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prolonged oral medication of Bayer E39 (cytostatic)].
    HESSE F; KAMPEN G
    Krebsarzt; 1957 Jun; 12(3):150-6. PubMed ID: 13450292
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of Bayer E 39 in otolaryngology; clinical and histological study].
    BAUER E
    Krebsarzt; 1957 Jun; 12(3):129-50. PubMed ID: 13450291
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical observations on the use of the compound E 39 in anticellular chemotherapy].
    CONSOLI G; RUSSO N
    Riforma Med; 1957 Jun; 71(22):624-9. PubMed ID: 13454506
    [No Abstract]   [Full Text] [Related]  

  • 9. [Notes on the use of a new cytostatic drug in chemotherapy of tumors].
    MELAMPI M
    Boll Soc Ital Biol Sper; 1956 Dec; 32(12):1619-22. PubMed ID: 13446158
    [No Abstract]   [Full Text] [Related]  

  • 10. [Temporary regression of cutaneous metastases due to reticulosarcoma in the treatment with Bayer E 39].
    ROSA L; GIUNGI F
    Riforma Med; 1957 Jun; 71(22):621-3. PubMed ID: 13454505
    [No Abstract]   [Full Text] [Related]  

  • 11. [Preliminary report on the use of a new cytotoxic drug in the treatment of tumors].
    ROSA L; GIUNGI F; FRANCO T
    Riforma Med; 1957 Jun; 71(22):619-20. PubMed ID: 13454504
    [No Abstract]   [Full Text] [Related]  

  • 12. [New antineoplastic drugs].
    DE SOCIO V
    Rass Int Clin Ter; 1957 Feb; 37(4):148-54. PubMed ID: 13420462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fundamentals & problems of chemotherapy of tumors].
    DOMAGK G
    Riforma Med; 1957 Jun; 71(22):601-3. PubMed ID: 13454500
    [No Abstract]   [Full Text] [Related]  

  • 14. [On radiotherapy and cytostatic therapy of rhabdomyosarcoma in the ORL area].
    Krückemeyer K
    Monatsschr Ohrenheilkd Laryngorhinol; 1965; 99(10):442-8. PubMed ID: 5882355
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experiences with ethyleneimino-quinone (E 39) in chemotherapy of various neoplasms].
    DI PIETRO S
    Riforma Med; 1957 Jun; 71(22):608-14. PubMed ID: 13454502
    [No Abstract]   [Full Text] [Related]  

  • 16. [Critical evaluation of certain results obtained with E-39].
    FARELLO G
    Riforma Med; 1957 Jun; 71(22):630-5. PubMed ID: 13454507
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical studies on carbazilquinone in the treatment of malignant diseases].
    Kurita S; Nishimura M; Ogawa M; Kamei Y; Ariyoshi Y
    Nihon Gan Chiryo Gakkai Shi; 1973 Jun; 8(2):119-27. PubMed ID: 4738331
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experiences with the cytostatic agent Bayer E 39 (ethyleneiminoquinone)].
    WOLF HJ; GERLICH N
    Krebsarzt; 1958 Jan; 13(1):27-30. PubMed ID: 13526247
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experiences with cytostatic treatment of malignant tumors with E 39 & A 139 (Bayer)].
    SEGSCHNEIDER PP; STROBEL E
    Munch Med Wochenschr; 1958 Dec; 100(51):2011-3. PubMed ID: 13622558
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contribution to the cytostatic therapy of leukemia with Bayer E-39].
    MEYTHALER F; HEGELEIN H
    Dtsch Med J; 1958 Jun; 9(6):297-301. PubMed ID: 13547928
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.